This prospective cohort study of 55 patients with inoperable esophageal cancer found that adding liquid nitrogen spray cryotherapy to systemic therapy improved both dysphagia and quality of life scores.
Endoscopy · 15 authors, 7 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This prospective cohort study of 55 patients with inoperable esophageal cancer found that adding liquid nitrogen spray cryotherapy to systemic therapy improved both dysphagia and quality of life scores.
This prospective multicenter cohort study enrolled 55 patients with inoperable esophageal cancer who received 175 liquid nitrogen spray cryotherapy procedures alongside systemic therapy. The findings suggest cryotherapy is a safe, effective option for palliating dysphagia and improving QoL in this population, with more intensive treatment schedules potentially offering greater benefit.